5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with enclomiphene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Clercq, E; Droogmans, G; Koolwijk, P; Lelkes, PI; Liekens, S; Manolopoulos, VG; Nilius, B; Peters, E; Voets, T | 1 |
| Derbyshire, ET; Krishna, S; Marques, CA; Mota, MM; Prudêncio, M; Staines, HM | 1 |
2 other study(ies) available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and enclomiphene
| Article | Year |
|---|---|
Inhibition of angiogenesis by blockers of volume-regulated anion channels.
Topics: Allantois; Angiogenesis Inhibitors; Animals; Aorta, Thoracic; Cattle; Cells, Cultured; Chick Embryo; Chorion; Clomiphene; Collagen; Drug Combinations; Endothelium, Vascular; Fibrin; Humans; In Vitro Techniques; Ion Channels; Laminin; Male; Mibefradil; Neovascularization, Physiologic; Nitrobenzoates; Proteoglycans; Rats; Rats, Wistar; Tamoxifen | 2000 |
Plasmodium berghei-infection induces volume-regulated anion channel-like activity in human hepatoma cells.
Topics: Animals; Anions; Cell Membrane Permeability; Cell Size; Chlorine; Clomiphene; Enzyme Inhibitors; Hepatocytes; Humans; Ion Channels; Mefloquine; Nitrobenzoates; Plasmodium berghei; Tamoxifen | 2009 |